Exhibit 99.1 Cytek Biosciences Reports Third Quarter 2025 Financial Results FREMONT, Calif., November 5, 2025 (GLOBE NEWSWIRE) – Cytek® Biosciences, Inc. ("Cytek Biosciences" or "Cytek") (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the third quarter ended September 30, 2025. Recent Highlights "Our third quarter results are encouraging and demonstrate the strength of our established brand and technology and our market leadership position," said Wenbin Jiang, ...